135 related articles for article (PubMed ID: 32155123)
1. Human-derived Acellular Dermal Matrix Grafts for Treatment of Diabetic Foot Ulcers: A Systematic Review and Meta-analysis.
Luthringer M; Mukherjee T; Arguello-Angarita M; Granick MS; Alvarez OM
Wounds; 2020 Feb; 32(2):57-65. PubMed ID: 32155123
[TBL] [Abstract][Full Text] [Related]
2. Human Reticular Acellular Dermal Matrix in the Healing of Chronic Diabetic Foot Ulcerations that Failed Standard Conservative Treatment: A Retrospective Crossover Study.
Zelen CM; Orgill DP; Serena TE; Galiano RD; Carter MJ; DiDomenico LA; Kaufman JP; Keller J; Young NJ; Li WW
Wounds; 2017 Feb; 29(2):39-45. PubMed ID: 28272011
[TBL] [Abstract][Full Text] [Related]
3. A prospective, randomised, controlled, multicentre clinical trial examining healing rates, safety and cost to closure of an acellular reticular allogenic human dermis versus standard of care in the treatment of chronic diabetic foot ulcers.
Zelen CM; Orgill DP; Serena T; Galiano R; Carter MJ; DiDomenico LA; Keller J; Kaufman J; Li WW
Int Wound J; 2017 Apr; 14(2):307-315. PubMed ID: 27073000
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness and safety of dermal matrix used for diabetic foot ulcer: a systematic review and meta-analysis of randomized controlled trials.
Sui L; Xie Q; Jiang HT; Li XD
BMC Endocr Disord; 2024 Feb; 24(1):23. PubMed ID: 38374102
[TBL] [Abstract][Full Text] [Related]
5. A randomized clinical trial of a human acellular dermal matrix demonstrated superior healing rates for chronic diabetic foot ulcers over conventional care and an active acellular dermal matrix comparator.
Cazzell S; Vayser D; Pham H; Walters J; Reyzelman A; Samsell B; Dorsch K; Moore M
Wound Repair Regen; 2017 May; 25(3):483-497. PubMed ID: 28544150
[TBL] [Abstract][Full Text] [Related]
6. An aseptically processed, acellular, reticular, allogenic human dermis improves healing in diabetic foot ulcers: A prospective, randomised, controlled, multicentre follow-up trial.
Zelen CM; Orgill DP; Serena TE; Galiano RE; Carter MJ; DiDomenico LA; Keller J; Kaufman JP; Li WW
Int Wound J; 2018 Oct; 15(5):731-739. PubMed ID: 29682897
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of acellular dermal matrix in diabetic foot ulcer treatment: A systematic review and meta-analysis.
Guo X; Mu D; Gao F
Int J Surg; 2017 Apr; 40():1-7. PubMed ID: 28232031
[TBL] [Abstract][Full Text] [Related]
8. [Meta-analysis on the clinical effects of allogenic acellular dermal matrix treatment for diabetic foot ulcer].
Xue CL; Hu ZC; Yang ZX; Li XJ
Zhonghua Shao Shang Za Zhi; 2016 Dec; 32(12):725-729. PubMed ID: 28043296
[No Abstract] [Full Text] [Related]
9. Human acellular dermal wound matrix for treatment of DFU: literature review and analysis.
Reyzelman AM; Bazarov I
J Wound Care; 2015 Mar; 24(3):128; 129-34. PubMed ID: 25764957
[TBL] [Abstract][Full Text] [Related]
10. A Randomized Controlled Trial Comparing a Human Acellular Dermal Matrix Versus Conventional Care for the Treatment of Venous Leg Ulcers.
Cazzell S
Wounds; 2019 Mar; 31(3):68-74. PubMed ID: 30720443
[TBL] [Abstract][Full Text] [Related]
11. Evidence for Healing Diabetic Foot Ulcers With Biologic Skin Substitutes: A Systematic Review and Meta-Analysis.
Gordon AJ; Alfonso AR; Nicholson J; Chiu ES
Ann Plast Surg; 2019 Oct; 83(4S Suppl 1):S31-S44. PubMed ID: 31513064
[TBL] [Abstract][Full Text] [Related]
12. Fetal bovine acellular dermal matrix for the closure of diabetic foot ulcers: a prospective randomised controlled trial.
Lantis JC; Snyder R; Reyzelman AM; Van Gils CC; Sigal F; Vayser D; Caporusso JM; Cazzell S; Lavery LA;
J Wound Care; 2021 Jul; 30(Sup7):S18-S27. PubMed ID: 34256588
[TBL] [Abstract][Full Text] [Related]
13. Composite Skin Grafting with Human Acellular Dermal Matrix Scaffold for Treatment of Diabetic Foot Ulcers: A Randomized Controlled Trial.
Hu Z; Zhu J; Cao X; Chen C; Li S; Guo D; Zhang J; Liu P; Shi F; Tang B
J Am Coll Surg; 2016 Jun; 222(6):1171-9. PubMed ID: 27068845
[TBL] [Abstract][Full Text] [Related]
14. The Efficacy and Safety of Acellular Matrix Therapy for Diabetic Foot Ulcers: A Meta-Analysis of Randomized Clinical Trials.
Huang W; Chen Y; Wang N; Yin G; Wei C; Xu W
J Diabetes Res; 2020; 2020():6245758. PubMed ID: 32090122
[TBL] [Abstract][Full Text] [Related]
15. Acellular Fish Skin Graft Use for Diabetic Lower Extremity Wound Healing: A Retrospective Study of 58 Ulcerations and a Literature Review.
Michael S; Winters C; Khan M
Wounds; 2019 Oct; 31(10):262-268. PubMed ID: 31730505
[TBL] [Abstract][Full Text] [Related]
16. Clinical Efficacy of Acellular Dermal Matrix Paste in Treating Diabetic Foot Ulcers.
Lee M; Jun D; Choi H; Kim J; Shin D
Wounds; 2020 Jan; 32(1):50-56. PubMed ID: 31876513
[TBL] [Abstract][Full Text] [Related]
17. A Prospective, Multicenter, Single-Arm Clinical Trial for Treatment of Complex Diabetic Foot Ulcers with Deep Exposure Using Acellular Dermal Matrix.
Cazzell S; Moyer PM; Samsell B; Dorsch K; McLean J; Moore MA
Adv Skin Wound Care; 2019 Sep; 32(9):409-415. PubMed ID: 31361269
[TBL] [Abstract][Full Text] [Related]
18. The use of PriMatrix, a fetal bovine acellular dermal matrix, in healing chronic diabetic foot ulcers: a prospective multicenter study.
Kavros SJ; Dutra T; Gonzalez-Cruz R; Liden B; Marcus B; McGuire J; Nazario-Guirau L
Adv Skin Wound Care; 2014 Aug; 27(8):356-62. PubMed ID: 25033310
[TBL] [Abstract][Full Text] [Related]
19. Use of injectable acellular dermal matrix combined with negative pressure wound therapy in open diabetic foot amputation.
Ahn J; Park HY; Shetty AA; Hwang W
J Wound Care; 2022 Apr; 31(4):310-320. PubMed ID: 35404696
[TBL] [Abstract][Full Text] [Related]
20. Human amniotic membrane allograft, a novel treatment for chronic diabetic foot ulcers: A systematic review and meta-analysis of randomised controlled trials.
Su YN; Zhao DY; Li YH; Yu TQ; Sun H; Wu XY; Zhou XQ; Li J
Int Wound J; 2020 Jun; 17(3):753-764. PubMed ID: 32119765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
